Vol. 3 No. 2 (2017), LETTERS TO THE EDITOR
Vol. 3 No. 2 (2017)

Patient with lymphangioleiomyomatosis and microscopic polyangiitis

LETTERS TO THE EDITOR
Published 2017-12-29
Marcos Vázquez
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Reumatología. San Lorenzo
Ana Soskin
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento y Servicio de Anatomía Patológica. San Lorenzo, Paraguay
Rafael Flor
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento y Servicio de Anatomía Patológica. San Lorenzo, Paraguay
Sonia Sanchez
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Cátedra de Neumología. San Lorenzo, Paraguay
Luis Montaner
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Cátedra de Neumología. San Lorenzo, Paraguay
Margarita Duarte
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas, Departamento de Reumatología. San Lorenzo, Paraguay
PDF (Spanish)

How to Cite

1.
Vázquez M, Soskin A, Flor R, Sanchez S, Montaner L, Duarte M. Patient with lymphangioleiomyomatosis and microscopic polyangiitis. Rev. parag. reumatol. [Internet]. 2017 Dec. 29 [cited 2026 Jan. 27];3(2):65-6. Available from: https://revista.spr.org.py/index.php/spr/article/view/79
APA ABNT Harvard Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Lymphangioleiomyomatosis is a rare disease, first described in 1918 by Lutenbacher in a patient with tuberous sclerosis. It belongs to the group of interstitial lung diseases of unknown etiology and predominantly affects premenopausal women.

PDF (Spanish)

References

(1) Belda FJ, Lloréns J. Ventilación mecánica en anestesia. 1ªed. Madrid: Aran Ediciones, 1999;p:315-327.

(2) Bonetti F, Chiodera P. Lymphangioleiomyomatosis and tuberoussclerosis: whereistheborder?EurRespir J 1996;9:399-401.

(3) Antón E, Casanova A, Xaubet A, Román A, Villena V, Montero MC, et al. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Registry. Sarcoidosis, vasculitis and diffuselungdiseases.

Sarcoidosis VascDiffuseLungDis 2009;26(2);85-91.

(4) Matsui K, Takeda K, Yu ZX, Zu-Xi Y, Travis WD, Moss J, Ferrans VJ. R ole foractivationofmatrixmetallo-proteinases in thepathogenesis ofpulmonarylymphangioleiomyomatosis. ArchPatholLabMed 2000;124: 267-75.

(5) Moss J, De Castro R, Patronas NJ, et al. Meningiomas in lymphangioleiomyomatosis. JAMA 2001;286:1879-1881.

(6) Tanaka H, Imada A, Morikawa T, Shibusa T, Satoh M, Sekine K et al. Diagnosis ofpulmonarylymphangioleiomyomatosisby HMB45 in surgicallytreatedspontaneouspneumothorax. EurRespir J 1995; 8:1879-82.

(7) S.K. Frankel,G.P. Cosgrove,A. Fischer,R.T. Meehan,K.K. Brown U pdate in the diagnosis and management of pulmonary vasculitis C hest, 129 (2006), pp. 452-465.

(8) M.I. Schwarz,K.K. Brown Small vessels vasculitis of the lung Thorax, 55 (2000), pp. 502-510.

(9) Bissler JJ, McCormack FX, Young LR, Elwing JM, ChuckG, Leonard JM, et al. Sirolimusforangiomyolipoma intuberoussclerosiscompl exorlymphangioleiomyomotosis.N Engl J Med 2008;358(2):140-15.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2017 Paraguayan Journal of Rheumatology

Downloads

Download data is not yet available.